P6617
Pristanic acid
≥97% (GC), ethanol solution
别名:
2,6,10,14-四甲基十五烷酸
Product Name
降植烷酸 溶液, mixture of isomers, ethanol solution, ≥97% (GC)
质量水平
方案
≥97% (GC)
表单
ethanol solution
储存温度
−20°C
SMILES字符串
CC(C)CCCC(C)CCCC(C)CCCC(C)C(O)=O
InChI
1S/C19H38O2/c1-15(2)9-6-10-16(3)11-7-12-17(4)13-8-14-18(5)19(20)21/h15-18H,6-14H2,1-5H3,(H,20,21)
InChI key
PAHGJZDQXIOYTH-UHFFFAOYSA-N
相关类别
生化/生理作用
饮食中脂肪酸（特别是植烷酸）的氧化产物。植烷酸通过α氧化反应进行氧化，生成降植烷酸，其随后通过过氧化物酶体β氧化降解。一些论文描述了一种或多种植烷酸或降植烷酸分解缺陷的一些先天代谢疾病。
警示用语：
Danger
危险声明
危险分类
Eye Irrit. 2 - Flam. Liq. 2
储存分类代码
3 - Flammable liquids
WGK
WGK 2
闪点(°F)
55.4 °F
闪点(°C)
13 °C
个人防护装备
Eyeshields, Faceshields, Gloves, type ABEK (EN14387) respirator filter
法规信息
危险化学品
历史批次信息供参考:
分析证书(COA)
Lot/Batch Number
S Ferdinandusse et al.
American journal of human genetics, 78(6), 1046-1052 (2006-05-11)
In this report, we describe the first known patient with a deficiency of sterol carrier protein X (SCPx), a peroxisomal enzyme with thiolase activity, which is required for the breakdown of branched-chain fatty acids. The patient presented with torticollis and
Antonella Peduto et al.
Molecular genetics and metabolism, 82(3), 224-230 (2004-07-06)
Peroxisomal disorders include a complex spectrum of diseases, characterized by a high heterogeneity from both the clinical and the biochemical points of view. Specific assays are required for the study of peroxisome metabolism. Among these, pipecolic acid evaluation is considered
Phytanic and pristanic acid are naturally occuring ligands.
Anna W M Zomer et al.
Advances in experimental medicine and biology, 544, 247-254 (2004-01-10)
R J Wanders et al.
European journal of pediatrics, 153(7 Suppl 1), S44-S48 (1994-01-01)
Peroxisomal disorders represent a recently recognized group of inherited diseases in man, now comprising 14 different disorders. If discussion is restricted to those peroxisomal disorders in which there is neurological involvement (thereby excluding hyperoxaluria and acatalasaemia), results over the least
D S Roe et al.
Molecular genetics and metabolism, 87(1), 40-47 (2005-11-22)
The differentiation of carnitine-acylcarnitine translocase deficiency (CACT) from carnitine palmitoyltransferase type II deficiency (CPT-II) and long-chain 3-hydroxyacyl-CoA dehydrogenase (LCHAD) deficiency from mitochondrial trifunctional protein deficiency (MTP) continues to be ambiguous using current acylcarnitine profiling techniques either from plasma or blood
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持